However, the same therapy may work differently for diverse diseases, even if caused by similar genetic rearrangement: CML and Ph+ ALL are usually due to different Bcr-Abl forms, i.e., p210/p230 and p190, respectively [67]. Here, GOLGA4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.